(Q58001062)

English

Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

based on heuristic

inferred from title

vaccine engineering

1 reference

based on heuristic

inferred from title

Francesco Forconi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Freda K. Stevenson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Catherine A King

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Surinder S Sahota

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Christopher K Kennaway

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Nigel H Russell

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

107

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

39-45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225361%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Antibody to a molecularly-defined antigen confined to a tumour cell surface

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Induction of B cell tumor dormancy by anti-idiotypic antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Prospects for the treatment of B cell tumors using idiotypic vaccination

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

DNA immunization induces protective immunity against B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Therapeutic strategies for B cell malignancies involving idiotype-anti-idiotype interactions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Folding and assembly of viral membrane proteins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Carrier-priming leads to hapten-specific suppression.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Effect of priming with carrier on response to conjugate vaccine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Stability engineering of antibody single-chain Fv fragments

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01452.X

21 January 2018

In vivo priming by DNA injection occurs predominantly by antigen transfer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782777

30 November 2018

V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782777

30 November 2018

Bacterial CpG DNA activates immune cells to signal infectious danger.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782777

30 November 2018

Carrier-induced, hapten-specific suppression: a problem of antigen presentation?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782777

30 November 2018

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782777

30 November 2018

Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782777

30 November 2018

Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782777

30 November 2018

Recognition of a B cell lymphoma by anti-idiotypic T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782777

30 November 2018

DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C

1 reference

https://pubmed.ncbi.nlm.nih.gov/12225361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12225361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12225361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12225361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/12225361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical trial of anti-idiotype therapy for B cell malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12225361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/12225361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/12225361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58001062&oldid=1863304691"